Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
10/2001
10/17/2001EP1144390A2 Kinase inhibitors
10/17/2001EP1144388A1 Acyl derivatives which treat vla-4 related disorders
10/17/2001EP1144384A1 Compounds which inhibit leukocyte adhesion mediated by vla-4
10/17/2001EP1143991A2 Inhibitors of h+k+ -atpase
10/17/2001EP1143977A1 2-oxy-benzoxazinone derivatives for the treatment of obesity
10/17/2001EP1143946A2 Use of benzodiazepines for treating autoimmune diseases induced by apoptosis
10/17/2001EP0833818B1 3-acylindoles as cb2 receptor agonists
10/17/2001EP0652871B1 Benzodiazepine derivatives
10/17/2001CN1318060A Sulfonyl oxazolones
10/17/2001CN1318059A Isoquinolines as urokinase inhibitors
10/17/2001CN1318057A 4-amino substituted-2-substituted-1,2,3,4-tetrahydroquinoliines as CETP inhibitors
10/17/2001CN1318055A Pyridine ketones useful as herbicides
10/17/2001CN1318053A Cyclopentanoue dihydropyridine compounds useful as potassium channel openers
10/17/2001CN1317970A Method for treating atherosclerosis empolying ap2 inhibitor and combination
10/17/2001CN1317968A 2-bustituted-1-piperidyl benzimidazole compounds as or/1-receptor agonists
10/17/2001CN1317965A Compounds having IgE affecting properties
10/17/2001CN1317480A One-step process for synthetizing 2-oxazolidone derivative
10/17/2001CN1073107C Process for 2-substituted benzo [b] thiophene compounds and intermediates thereof
10/17/2001CN1073106C Taxoids compound, preparation thereof, and pharmaceutical compsns. contg. same
10/17/2001CN1073090C 1,3,4-oxadiazine derivatives and their use as pesticides
10/17/2001CN1073089C Benzodizaepine derivtive, its compsns. and use of preparing medicines
10/16/2001US6303793 Intermediates for cyclin-dependent kinase inhibitors
10/16/2001US6303791 One pot synthesis of 2-oxazolidinone derivatives
10/16/2001US6303786 Salt formation in a solvent
10/16/2001US6303783 1- (3-Heterocyclylphenyl) isothiourea, -isourea, -guanidine and -amidine herbicidal agents
10/16/2001US6303639 Propanolamine derivatives substituted by heterocyclic radicals, processes for their preparation, pharmaceuticals comprising these compounds and their use
10/16/2001US6303638 Substituted pyridines as modulators of the mammalian neuronal nicotinic acetylcholine receptor
10/16/2001US6303627 For therapy of physiological and psychological disorders
10/16/2001US6303615 2,3 disubstituded-4(3H)-quinazolinones
10/16/2001US6303609 Used for the inhibition of platelet aggregation, as thrombolytics, and/or for the treatment of thromboembolic disorders
10/16/2001US6303600 Substituted azabicyclic compounds
10/16/2001US6303593 For therapy human immunodeficiency virus infection, aquired immunodeficiency syndrome (aids), inflammatory and immunoregulatory disorder or disease, asthma, allergic rhinitis, dermatitis, conjunctivitis, atherosclerosis
10/11/2001WO2001074820A1 Novel derivatives and analogues of galanthamin
10/11/2001WO2001074808A1 Novel 1,2,3,4-tetrahydrosioquinoline, their preparation method and their use as fungicides
10/11/2001WO2001074771A1 Pyrrole-2,5-dione derivatives for the treatment of diabetes
10/11/2001WO2001074344A2 Small organic molecule regulators of cell proliferation
10/11/2001WO2001025210A3 Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and the use thereof as adenosine receptor ligands
10/11/2001WO2001021585A3 Bis(1-aziridino-1-hydroxyiminomethyl)-derivatives, method for the production thereof and use thereof as anti-tumoral agents
10/11/2001US20010029299 Psychological disorders; sleep disorders; anticonvulsants; cognition activators; drug abruse
10/11/2001DE10017539A1 New 6-acylamino-4-amino-quinazoline or quinoline derivatives, are tyrosine kinase-mediated signal transduction inhibitors useful e.g. for treating tumors or respiratory or gastrointestinal diseases
10/11/2001DE10015836A1 New epothilone derivatives used for treating e.g. malignant melanoma, breast carcinoma, psoriasis, multiple sclerosis and arthritis
10/11/2001CA2405126A1 Novel 1,2,3,4-tetrahydrosioquinoline, their preparation method and their use as fungicides
10/11/2001CA2404413A1 Small organic molecule regulators of cell proliferation
10/11/2001CA2368966A1 New derivatives and analogues of galanthamine
10/10/2001EP1142884A1 Oxazepine derivatives and drugs containing the same
10/10/2001EP1142883A1 Novel heterocyclic compounds and drug compositions containing the same
10/10/2001EP1142867A2 Cell adhesion inhibitors
10/10/2001EP1140944A1 Epothilone derivatives and their use as antitumor agents
10/10/2001EP1140927A1 1,4-benzodiazepinone derivatives and their use as integrin antagonists
10/10/2001EP1140926A1 Azadioxacycloalkenes and their use for combating harmful fungi and animal pests
10/10/2001EP1140925A1 (3,4 dihydro-2h-benzo[1,4] oxazinyl-methyl)- 3-(1h-indol-3- yl)-alkyl -amines
10/10/2001EP1140924A1 Piperazine derivatives
10/10/2001EP1140923A1 Method for preparing (r)- (+) -3 1- 2-( 4-benzoyl- 2-(3,4- difluorophenyl)morpholin- 2-yl)ethyl]- 4-phenylpiperidin -4-yl -1,1- dimethylurea, its salts solvates and/or hydrates
10/10/2001EP1140922A1 4-trifluoromethyl-3-oxadiazolyl pyridines, methods for the production thereof, agents containing these compounds, and their use as pesticides
10/10/2001EP1140921A1 4-trifluoromethyl-3-oxazolylpyridines, method for producing them, products containing the same, and their use as pesticides
10/10/2001EP1140920A1 Piperidines as ccr5 modulators
10/10/2001EP1140918A1 Thrombin inhibitors
10/10/2001EP1140916A1 Heteroaryl-cyclic acetals
10/10/2001EP1140914A1 Non-peptide nk1 receptors antagonists
10/10/2001EP1140908A1 Triazole compounds with dopamine-d3-receptor affinity
10/10/2001EP1140907A1 Triazole compounds with dopamine-d3-receptor affinity
10/10/2001EP1140904A1 Farnesyl protein transferase inhibitors
10/10/2001EP1140901A2 Substituted (aminoiminomethyl or aminomethyl)benzoheteroaryl compounds as factor xa inhibitors
10/10/2001EP1140876A1 Morpholinone and morpholine derivatives and uses thereof
10/10/2001EP1140871A1 Thrombin or factor xa inhibitors
10/10/2001EP1140862A1 THROMBIN OR FACTOR Xa INHIBITORS
10/10/2001EP1140860A1 Pyrimidine compounds
10/10/2001EP1140859A2 (hetero)aryl-bicyclic heteroaryl derivatives, their preparation and their use as protease inhibitors
10/10/2001EP1140850A1 Quinolinecarboxamides as antiviral agents
10/10/2001EP1140835A1 3,3-biarylpiperidine and 2,2-biarylmorpholine derivatives
10/10/2001EP1140834A1 Heterocyclic piperidines as modulators of chemokine receptor activity
10/10/2001EP1140828A1 3-azabicyclo[3.1.0]hexane derivatives as opiate receptors ligands
10/10/2001EP1140814A2 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
10/10/2001EP1140809A1 New biphenyl and biphenyl-analogous compounds as integrin antagonists
10/10/2001EP1140784A2 Ion channel modulating agents
10/10/2001EP1140194A2 Use of cyclooxygenase-2 inhibitor, a matrix metallaproteinase inhibitor, an antineoplastic agent and optionally radiation as a combined treatment of neoplasia
10/10/2001EP1140193A2 Use of an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
10/10/2001EP1140192A2 Use of a cyclooxygenase-2 inhibitor and one or more antineoplastic agents for combination therapy in neoplasia
10/10/2001EP1140183A1 Use of a matrix metalloproteinase inhibitor and an integrin antagonist in the treatment of neoplasia
10/10/2001EP1140182A2 Use of a matrix metalloproteinase inhibitor together with an antineoplastic agent, optionally also together with radiation, in the treatment of neoplasia
10/10/2001EP1140179A2 Use of a cyclooxygenase 2 inhibitor and an integrin antagonist as a combination therapy in the treatment of neoplasia
10/10/2001EP1140178A2 Use of a matrix metallaproteinase inhibitor and radiation as a combined treatment of neoplasia
10/10/2001EP1140177A2 Use of an integrin antagonist and radiation in the treatment of neoplasia
10/10/2001EP1140087A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
10/10/2001EP1140086A1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
10/10/2001EP1140085A1 Azabicycloalkanes as ccr5 modulators
10/10/2001EP0832065B1 Substituted n-(indole-2-carbonyl)-glycinamides and derivatives as glycogen phosphorylase inhibitors
10/10/2001EP0759907B1 Substituted 3-phenylpyrazoles for use as herbicides
10/10/2001CN1317004A Benzoyl derivatives, method for producing them and their use as herbicides and plant growth regulators
10/10/2001CN1317003A Pyrimidine derivatives exhibiting antitumor activity
10/10/2001CN1316995A Hydroxy 2-pipecolate hydroxamide acid derivatives as MMP inhititors
10/10/2001CN1316993A 4,4-biarylpiperidime derivatives with opioid receptor activity
10/10/2001CN1072669C Benzimidazole compounds and their use as modulators of the GABAA receptor complex
10/10/2001CN1072666C (Azetidin-1-ylalkyl) lactams as tachykinin antagonists
10/10/2001CN1072655C New Heterocyclic aminomethyl compounds, process for preparing them and pharmaceutical composition containing their
10/10/2001CN1072649C Benzoxazepine compounds, their production method and use
10/09/2001US6300363 Indole compounds as COX-2 inhibitors
10/09/2001US6300355 For therapy of cancer
10/09/2001US6300344 Heterocyclic compounds
10/09/2001CA2218306C Method of preventing allograft rejection
1 ... 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 ... 647